These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25155937)

  • 61. Guanfacine for attention deficit and hyperactivity disorder in pediatrics: a systematic review and meta-analysis.
    Ruggiero S; Clavenna A; Reale L; Capuano A; Rossi F; Bonati M
    Eur Neuropsychopharmacol; 2014 Oct; 24(10):1578-90. PubMed ID: 25156577
    [TBL] [Abstract][Full Text] [Related]  

  • 62. STX1A gene variations contribute to the susceptibility of children attention-deficit/hyperactivity disorder: a case-control association study.
    Wang M; Gu X; Huang X; Zhang Q; Chen X; Wu J
    Eur Arch Psychiatry Clin Neurosci; 2019 Sep; 269(6):689-699. PubMed ID: 30976917
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Exocytosis-related genes and response to methylphenidate treatment in adults with ADHD.
    da Silva BS; Cupertino RB; Rovaris DL; Schuch JB; Kappel DB; Müller D; Bandeira CE; Victor MM; Karam RG; Mota NR; Rohde LA; Contini V; Grevet EH; Bau CHD
    Mol Psychiatry; 2018 Jun; 23(6):1446-1452. PubMed ID: 28461697
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD.
    Kambeitz J; Romanos M; Ettinger U
    Pharmacogenomics J; 2014 Feb; 14(1):77-84. PubMed ID: 23588108
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Should we keep on? Looking into pharmacogenomics of ADHD in adulthood from a different perspective.
    Rovaris DL; Mota NR; da Silva BS; Girardi P; Victor MM; Grevet EH; Bau CH; Contini V
    Pharmacogenomics; 2014 Jul; 15(10):1365-81. PubMed ID: 25155937
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review.
    Contini V; Rovaris DL; Victor MM; Grevet EH; Rohde LA; Bau CH
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):555-60. PubMed ID: 22709890
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics.
    Polanczyk G; Zeni C; Genro JP; Roman T; Hutz MH; Rohde LA
    Pharmacogenomics; 2005 Apr; 6(3):225-34. PubMed ID: 16013954
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies.
    Bonvicini C; Faraone SV; Scassellati C
    Mol Psychiatry; 2016 Jul; 21(7):872-84. PubMed ID: 27217152
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Attention-deficit/hyperactivity disorder pharmacogenomics.
    McGough JJ
    Biol Psychiatry; 2005 Jun; 57(11):1367-73. PubMed ID: 15950009
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A current update on ADHD pharmacogenomics.
    Kieling C; Genro JP; Hutz MH; Rohde LA
    Pharmacogenomics; 2010 Mar; 11(3):407-19. PubMed ID: 20235795
    [TBL] [Abstract][Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.